100 related articles for article (PubMed ID: 22394334)
1. Predictive value of the vitamin K epoxide reductase complex subunit 1 G-1639A and C1173T single nucleotide polymorphisms in retinal vein occlusion.
Ortak H; Söğüt E; Demir H; Ardagil A; Benli I; Sahin S
Clin Exp Ophthalmol; 2012; 40(7):743-8. PubMed ID: 22394334
[TBL] [Abstract][Full Text] [Related]
2. Role of the vitamin K epoxide reductase complex subunit 1 (VKORC1) -1639G>A gene polymorphism in patients with retinal vein occlusion.
Weger M; Steinbrugger I; Renner W; Pöschl EM; Brockmann T; Rabensteiner DF; El-Shabrawi Y; Haas A
Curr Eye Res; 2013 Dec; 38(12):1278-82. PubMed ID: 23972066
[TBL] [Abstract][Full Text] [Related]
3. VKORC1 C1173T and VKORC1 G-1639A gene polymorphisms in Turkish Behçet's patients with ocular and non-ocular involvement.
Demir HD; Ortak H; Şahin Ş; Ateş Ö; Benli I; İnanır A
Ophthalmic Genet; 2014 Mar; 35(1):7-11. PubMed ID: 23362849
[TBL] [Abstract][Full Text] [Related]
4. GENETIC ASSOCIATION BETWEEN ARTERIAL STIFFNESS-RELATED GENE POLYMORPHISMS IN BRVO AND CRVO PATIENTS IN A TURKISH POPULATION.
Demir S; Ortak H; Benli İ; Alim S; Bütün İ; Güneş A; Ateş Ö
Retina; 2015 Oct; 35(10):2043-51. PubMed ID: 25932559
[TBL] [Abstract][Full Text] [Related]
5. G-1639A but Not C1173T
Dubovyk YI; Harbuzova VY; Ataman AV
Biomed Res Int; 2016; 2016():1298198. PubMed ID: 27703968
[TBL] [Abstract][Full Text] [Related]
6. [Retinal vascular occlusion and polymorphisms in genes coding for components of vitamin K cycle].
Kakhktsyan SS; Moshetova LK; Turkina KI; Sychev DA
Vestn Oftalmol; 2016; 132(4):94-97. PubMed ID: 28635929
[TBL] [Abstract][Full Text] [Related]
7. Vitamin K epoxide reductase (VKORC1) gene mutations in osteoporosis: A pilot study.
Holzer G; Grasse AV; Zehetmayer S; Bencur P; Bieglmayer C; Mannhalter C
Transl Res; 2010 Jul; 156(1):37-44. PubMed ID: 20621035
[TBL] [Abstract][Full Text] [Related]
8. Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion.
Ortak H; Demir S; Ateş O; Söğüt E; Alim S; Benli I
Exp Eye Res; 2013 Aug; 113():151-5. PubMed ID: 23791966
[TBL] [Abstract][Full Text] [Related]
9. Association of methylenetetrahydrofolate reductase (A1298C and C677T) polymorphisms with retinal vein occlusion in Tunisian patients.
Mrad M; Wathek C; Saleh MB; Baatour M; Rannen R; Lamine K; Gabsi S; Gritli N; Fekih-Mrissa N
Transfus Apher Sci; 2014 Apr; 50(2):283-7. PubMed ID: 24440586
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2-Center prospective cohort study.
Suh JW; Baek SH; Park JS; Kang HJ; Chae IH; Choi DJ; Park HJ; Kim PJ; Seung KB; Kim HS
Am Heart J; 2009 May; 157(5):908-12. PubMed ID: 19376320
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin.
Teh LK; Langmia IM; Fazleen Haslinda MH; Ngow HA; Roziah MJ; Harun R; Zakaria ZA; Salleh MZ
J Clin Pharm Ther; 2012 Apr; 37(2):232-6. PubMed ID: 21507031
[TBL] [Abstract][Full Text] [Related]
13.
Osman NA; El-Abd N; Nasrallah M
Saudi J Kidney Dis Transpl; 2016; 27(5):908-915. PubMed ID: 27751997
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: results from the EDITH Study.
Lacut K; Larramendy-Gozalo C; Le Gal G; Duchemin J; Mercier B; Gourhant L; Mottier D; Becquemont L; Oger E; Verstuyft C
J Thromb Haemost; 2007 Oct; 5(10):2020-4. PubMed ID: 17883698
[TBL] [Abstract][Full Text] [Related]
15. [Development of the high resolution melting method for genotyping CYP2C9*3 (1075A/C, rs1057910) and VKORC1 (-1639A/G, rs9923231)].
Cui GL; Ding H; Xu YJ; Chen C; Wang DW
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):477-81. PubMed ID: 22943641
[TBL] [Abstract][Full Text] [Related]
16. [Oral anticoagulation and pharmacogenetics: importance in the clinical setting].
Benusiglio PR; Desmeules J; de Moerloose P; Dayer P
Rev Med Suisse; 2007 Sep; 3(124):2030, 2033-4, 2036. PubMed ID: 17955831
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of paraoxonase 1 gene variant L55M in retinal vein occlusion.
Ortak H; Söğüt E; Ateş O; Erkorkmaz U; Benli I; Akbas A; Demir S; Ozyurt H
Mol Vis; 2013; 19():486-xxx. PubMed ID: 23441121
[TBL] [Abstract][Full Text] [Related]
18. Role of thrombophilic gene polymorphisms in branch retinal vein occlusion.
Weger M; Renner W; Steinbrugger I; Cichocki L; Temmel W; Stanger O; El-Shabrawi Y; Lechner H; Schmut O; Haas A
Ophthalmology; 2005 Nov; 112(11):1910-5. PubMed ID: 16157382
[TBL] [Abstract][Full Text] [Related]
19. Sequence variation in vitamin K epoxide reductase gene is associated with survival and progressive coronary calcification in chronic kidney disease.
Holden RM; Booth SL; Tuttle A; James PD; Morton AR; Hopman WM; Nolan RL; Garland JS
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1591-6. PubMed ID: 24855061
[TBL] [Abstract][Full Text] [Related]
20. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection).
Wang Y; Zhang W; Zhang Y; Yang Y; Sun L; Hu S; Chen J; Zhang C; Zheng Y; Zhen Y; Sun K; Fu C; Yang T; Wang J; Sun J; Wu H; Glasgow WC; Hui R
Circulation; 2006 Mar; 113(12):1615-21. PubMed ID: 16549638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
